Chemoinformaics analysis of 2-(2-Hydroxyvinyl)-1- methyl-4-propoxyphthalate
| Molecular Weight | 280.276 | nRot | 6 |
| Heavy Atom Molecular Weight | 264.148 | nRig | 9 |
| Exact Molecular Weight | 280.096 | nRing | 1 |
| Solubility: LogS | -1.143 | nHRing | 0 |
| Solubility: LogP | 0.78 | No. of Aliphatic Rings | 1 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 38.8607 |
| nHD | 1 | BPOL | 21.2593 |
| QED | 0.688 |
| Synth | 4.27 |
| Natural Product Likeliness | 0.932 |
| NR-PPAR-gamma | 0.738 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.455 |
| CACO-2 | -5.787 |
| MDCK | 0.00004 |
| BBB | 0.566 |
| PPB | 0.559624 |
| VDSS | 0.217 |
| FU | 0.517899 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.678 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.084 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.725 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.061 |
| CYP3a4-inh | 0.047 |
| CYP3a4-sub | 0.12 |
| CL | 1.772 |
| T12 | 0.808 |
| hERG | 0.004 |
| Ames | 0.04 |
| ROA | 0.078 |
| SkinSen | 0.773 |
| Carcinogencity | 0.079 |
| EI | 0.873 |
| Respiratory | 0.906 |
| NR-Aromatase | 0.576 |
| Antiviral | Yes |
| Prediction | 0.82688 |